M&A Deal Summary |
|
---|---|
Date | 2014-09-29 |
Target | Lumara Health |
Sector | Life Science |
Buyer(s) | AMAG Pharmaceuticals |
Deal Type | Add-on Acquisition |
Deal Value | 675M USD |
Advisor(s) | Perella Weinberg Partners T.R. Winston & Co. LLC (Financial) Dechert (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1981 |
Sector | Life Science |
Employees | 440 |
Revenue | 328M USD (2019) |
AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company that markets Feraheme (ferumoxytol) Injection and MuGard® Mucoadhesive Oral Wound Rinse. AMAG Pharmaceuticals was formed in 1981 and is based in Waltham, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 1 of 3 |
Sector (Life Science) | 1 of 2 |
Type (Add-on Acquisition) | 1 of 3 |
State (Montana) | 1 of 1 |
Country (United States) | 1 of 3 |
Year (2014) | 1 of 1 |
Size (of disclosed) | 2 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-08-17 |
Cord Blood Registry
San Bruno, California, United States CBR Systems is a late-stage medical devices company with the leading market position in providing the collection, processing and cryogenically-frozen storage of stem cells. |
Buy | $700M |